Here's why Ansell Limited, ResMed Inc, Fisher & Paykel Healthcare Corp Ltd and Somnomed Limited are hitting new highs

The health care sector looks to be one of the safest places to invest during market tumbles.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

So far this week the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has already lost 2.5% and while the market has clawed back some of its early steep losses, Aussie investors are almost certainly facing the prospect of a down week on the market.

The rapid decline in share prices of a number of so-called blue-chip stocks has been alarming and certainly caught many investors off-guard.

It would appear that now is a time to be extra vigilant and conservative in your valuations as well as ensuring your portfolio is adequately positioned for defense in case the market volatility gets even worse.

Time to play defense not offense

While many leading stocks have sunk to new 52-week lows this week, a small handful have bucked the trend and been climbing to fresh highs.

Perhaps not surprisingly a number of the stocks gaining ground have come from the health care sector. Ansell Limited (ASX: ANN), ResMed Inc. (CHESS) (ASX: RMD), Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) and Somnomed Limited (ASX: SOM) have all managed to hit fresh new yearly highs and in some cases all-time highs.

What is it about the health sector?

The beauty of many health care businesses is that their products and services are non-discretionary which means that their respective business models are not heavily dependent on economic activity or swayed by such things as oil prices.

What's more, they also often enjoy a degree of pricing power which allows them to remain (very) profitable, even during economically stressful times.

A third factor in the above cases is that they are global businesses with exposure to US dollars which is an added tailwind.

From a technical point of view for portfolio management, these stocks could be described as having low betas. This is particularly true of the medical device companies ResMed, Somnomed and Fisher & Paykel. Ansell meanwhile is somewhat exposed to broader economic trends via its industrial gloves business so its beta would be higher.

The performance of these four stocks this week should act as a reminder for investors as to one of the great advantages of running a diversified portfolio and what diversity really is. Uncorrelated business models are an important factor to consider in your portfolio construction process.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.  

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »